Intuitive Surgical, Inc. ISRG
405.18
5.66
1.42%
as of 25 Sep
- Market cap
- $140.7B
- P/E
- 45.8×
Follow ISRG
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Intuitive Surgical, Inc. (ISRG) Return on equity
Intuitive Surgical, Inc.'s return on equity over the twelve months to 30 June 2026 was 17.3%, up 0.8 percentage points from fiscal 2025 (16.6%). Over the past ten years it has ranged from 11.5% (fiscal 2022) to 19.7% (fiscal 2018); the current reading is higher than 82% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 16.6% | 1.05 |
| FY2024 | 15.5% | 0.85 |
| FY2023 | 14.7% | 3.20 |
| FY2022 | 11.5% | (4.23) |
| FY2021 | 15.7% | 3.94 |
| FY2020 | 11.8% | (6.66) |
| FY2019 | 18.4% | (1.25) |
| FY2018 | 19.7% | 6.96 |
| FY2017 | 12.7% | (1.91) |
| FY2016 | 14.6% | (0.68) |
Against its own ten years
Low 11.5%
High 19.7%
Ten-year median
15.3%
Current reading's percentile
82
Return on equity against peers
| Company | Return on equity |
|---|---|
| SOLV Solventum Corporation compare | 34.0% |
| RMD ResMed Inc. compare | 24.3% |
| WST West Pharmaceutical Services, Inc. compare | 19.1% |
| ISRG Intuitive Surgical, Inc. | 17.3% |
| BDX Becton, Dickinson and Company compare | 3.77% |
| ALC Alcon compare | 2.94% |
| RGEN Repligen Corporation compare | 1.99% |
| MDLN Medline Inc. compare | 0.00% |
| BAX Baxter International Inc. compare | −15.8% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ISRG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement